Table 2

Associations of treatment level with pulmonary outcomes at follow-up

Models using absolute valuesModels using % of predicted
Beta (95% CI)P valueBeta (95% CI)P value
6MWT (metres)
 Inpatient−39 (−77 to −1.6)0.043−4.8 (−11 to 0.92)0.10
 ICU−96 (−143 to −50)<0.0001−14 (−21 to −7.0)0.0001
FVC (litres)
 Inpatient0.09 (−0.23 to 0.41)0.90−1.4 (−8.0 to 5.2)0.69
 ICU−0.34 (−0.73 to 0.05)0.09−7.7 (−16 to 0.5)0.07
FEV1 (litres)
 Inpatient0.06 (−0.16 to 0.3)0.57−2.0 (−8.8 to 4.7)0.55
 ICU−0.13 (−0.41 to 0.14)0.34−4.5 (−13 to 3.8)0.29
FEV1/FVC (%)
 Inpatient1.6 (−6.2 to 3.0)0.51
 ICU2.1 (−3.5 to 7.7)0.46
DLCO (mL/min/mm Hg)
 Inpatient−0.31 (−0.95 to 0.32)0.33−7.9 (−14 to −1.8)0.01
 ICU−1.6 (−2.4 to −0.83)<0.0001−20 (−27 to −13)<0.0001
Saturation after 6MWT (%)
 Inpatient−0.21 (−1.4 to 0.9)0.71
 ICU−2.1 (−3.5 to −0.71)0.004
mMRC
 Inpatient1.0 (0.006 to 2.0)0.049
 ICU0.75 (−0.38 to 1.9)0.19
  • FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; ICU, intensive care unit; mMRC, modified Medical Research Council; 6MWT, 6 min walk test.